DANCANN PHARMA A/S financial statements, including revenue, expenses, profit, and loss

The total revenue of DANCAN for the last quarter is 1.85 M DKK, and it's 51.89% lower compared to the previous quarter. The net income of Q3 24 is -2.85 M DKK.